CClinicalTrials.gg
CompletedNCT07318844Updated Jan 6, 2026

Stroke Volume at Rest and During Exercise in Healthy Volunteers

An interventional study of Cardiopulmonary exercise test in Healthy, sponsored by Rigshospitalet, Denmark. Completed at 1 site in Denmark. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-06.

Sponsored by Rigshospitalet, Denmark · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
12
Allocation
Not applicable
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Background Changes in cardiac output, driven by increased heart rate and stroke volume, are crucial for oxygen delivery during acute exercise and influence maximal oxygen uptake (VO₂max). Thoracic electrical bioimpedance provides a non-invasive alternative to traditional invasive methods by estimating stroke volume through impedance changes during ventricular filling and emptying. However, its test-retest reliability remains uncertain, requiring further investigation for use in acute and long-term training assessments.

Methods Inclusion: 12 healthy individuals (six males, six females) Exclusion: Known ischaemic heart disease, known heart failure, symptoms of disease within 2 weeks prior to the study, known malignant disease, claudication, pregnancy, unstable cardiac arrhythmic disease, renal or liver dysfunction, known chronic lung disease Design: Test-retest study of thoracic electrical bioimpedance-based stroke volume

Intervention: Acute exercise bout on a bicycle ergometer Statistical design: Rest-to-exercise changes, as well as between-day smallest real difference, coefficient of variation and intraclass correlation coefficient Sample size: Since this is a pilot study, the sample size is set at 12 in accordance with current recommendations.

Perspective The results are relevant for designing future studies in which stroke volume is measured and compared in response to various interventions at rest and during exercise.

02

Conditions studied

  • Healthy

Keywords

  • stroke volume
  • test-retest
  • Acute exercise
03

In context

Lead sponsor

Rigshospitalet, Denmark is the lead sponsor of 1,017 studies on the registry; 183 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Men and women
  • 18-70 years

Exclusion criteria

Exclusion criteria

  • Known chronic lung disease
  • Known ischaemic heart disease
  • Known heart failure
  • Symptoms of disease within 2 weeks prior to the study
  • Known malignant disease
  • Claudication
  • Pregnancy
  • Unstable cardiac arrhythmic disease
  • Renal or liver dysfunction
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
12 participants (actual)

Study arms

  • Experimental
    Exercise bout

    A cardiopulmonary exercise test (CPET), during which stroke volume and heart rate are continuously measured

    Other: Cardiopulmonary exercise test

Interventions

  • OtherCardiopulmonary exercise test

    The two study days are identical, and consist of stroke volume, heart rate and non-invasive blood pressure measurements during upright rest, in the supine position, and during incremental exercise (CPET).

06

What researchers measure

Primary outcomes

  1. Between-day smallest real difference (SRD) for stroke volume during upright rest

    Time frame: 2-10 days

  2. Between-day coefficient of variance (CV) for for stroke volume during upright rest

    Time frame: 2-10 days

Secondary outcomes

  1. Between-day smallest real difference (SRD) for stroke volume during supine rest

    Time frame: 2-10 days

  2. Between-day coefficient of variance (CV) for stroke volume during supine rest

    Time frame: 2-10 days

  3. Between-day SRD for stroke volume at 60% of maximal workload (Wmax) during CPET

    Time frame: 2-10 days

  4. Between-day CV for stroke volume at 60% of Wmax during CPET

    Time frame: 2-10 days

Other outcomes

  1. Between-day SRD for stroke volume at 40% of Wmax during CPET

    Time frame: 2-10 days

  2. Between-day CV for stroke volume at 40% of Wmax during CPET

    Time frame: 2-10 days

  3. Between-day SRD for stroke volume at 80% of Wmax during CPET

    Time frame: 2-10 days

  4. Between-day CV for stroke volume at 80% of Wmax during CPET

    Time frame: 2-10 days

  5. Between-day SRD for stroke volume at Wmax during CPET

    Time frame: 2-10 days

  6. Between-day CV for stroke volume at Wmax during CPET

    Time frame: 2-10 days

  7. Between-day intraclass correlation coefficient (ICC) for stroke volume during upright rest

    Time frame: 2-10 days

  8. Between-day ICC for stroke volume during supine rest

    Time frame: 2-10 days

  9. Between-day ICC for stroke volume at 60% of Wmax during CPET

    Time frame: 2-10 days

  10. Between-day ICC for stroke volume at 40% of Wmax during CPET

    Time frame: 2-10 days

  11. Between-day ICC for stroke volume at 80% of Wmax during CPET

    Time frame: 2-10 days

  12. Between-day ICC for stroke volume at Wmax during CPET

    Time frame: 2-10 days

  13. Between-day SRD for cardiac output (measured as the product of stroke volume and heart rate) during upright rest

    Time frame: 2-10 days

  14. Between-day CV for for cardiac output during upright rest

    Time frame: 2-10 days

  15. Between-day ICC for for cardiac output during upright rest

    Time frame: 2-10 days

  16. Between-day SRD for cardiac output during supine rest

    Time frame: 2-10 days

  17. Between-day CV for for cardiac output during supine rest

    Time frame: 2-10 days

  18. Between-day ICC for for cardiac output during supine rest

    Time frame: 2-10 days

  19. Between-day SRD for cardiac output at 60% of Wmax during CPET

    Time frame: 2-10 days

  20. Between-day CV for cardiac output at 60% of Wmax during CPET

    Time frame: 2-10 days

  21. Between-day ICC for cardiac output at 60% of Wmax during CPET

    Time frame: 2-10 days

  22. Between-day SRD for cardiac output at 40% of Wmax during CPET

    Time frame: 2-10 days

  23. Between-day CV for cardiac output at 40% of Wmax during CPET

    Time frame: 2-10 days

  24. Between-day ICC for cardiac output at 40% of Wmax during CPET

    Time frame: 2-10 days

  25. Between-day SRD for cardiac output at 80% of Wmax during CPET

    Time frame: 2-10 days

  26. Between-day CV for cardiac output at 80% of Wmax during CPET

    Time frame: 2-10 days

  27. Between-day ICC for cardiac output at 80% of Wmax during CPET

    Time frame: 2-10 days

  28. Between-day SRD for cardiac output at Wmax during CPET

    Time frame: 2-10 days

  29. Between-day CV for cardiac output at Wmax during CPET

    Time frame: 2-10 days

  30. Between-day ICC for cardiac output at Wmax during CPET

    Time frame: 2-10 days

  31. Between-day SRD for heart rate (measured with the CPET equipment) during upright rest

    Time frame: 2-10 days

  32. Between-day CV for for heart rate during upright rest

    Time frame: 2-10 days

  33. Between-day ICC for for heart rate during upright rest

    Time frame: 2-10 days

  34. Between-day SRD for heart rate during supine rest

    Time frame: 2-10 days

  35. Between-day CV for for heart rate during supine rest

    Time frame: 2-10 days

  36. Between-day ICC for for heart rate during supine rest

    Time frame: 2-10 days

  37. Between-day SRD for heart rate at 60% of Wmax during CPET

    Time frame: 2-10 days

  38. Between-day CV for heart rate at 60% of Wmax during CPET

    Time frame: 2-10 days

  39. Between-day ICC for heart rate at 60% of Wmax during CPET

    Time frame: 2-10 days

  40. Between-day SRD for heart rate at 40% of Wmax during CPET

    Time frame: 2-10 days

  41. Between-day CV for heart rate at 40% of Wmax during CPET

    Time frame: 2-10 days

  42. Between-day ICC for heart rate at 40% of Wmax during CPET

    Time frame: 2-10 days

  43. Between-day SRD for heart rate at 80% of Wmax during CPET

    Time frame: 2-10 days

  44. Between-day CV for heart rate at 80% of Wmax during CPET

    Time frame: 2-10 days

  45. Between-day ICC for heart rate at 80% of Wmax during CPET

    Time frame: 2-10 days

  46. Between-day SRD for heart rate at Wmax during CPET

    Time frame: 2-10 days

  47. Between-day CV for heart rate at Wmax during CPET

    Time frame: 2-10 days

  48. Between-day ICC for heart rate at Wmax during CPET

    Time frame: 2-10 days

  49. Uright-to supine changes in stroke volume, heart-rate and cardiac output and arterial blood pressure at rest

    Time frame: 2-10 days

  50. Changes in stroke volume from upright rest to exercise at 40%, 60%, 80% and 100% of Wmax.

    Time frame: 2-10 days

  51. Changes in cardiac output from upright rest to exercise at 40%, 60%, 80% and 100% of Wmax.

    Time frame: 2-10 days

  52. Changes in arterial blood pressure from upright rest to exercise at 40%, 60%, 80% and 100% of Wmax.

    Time frame: 2-10 days

07

Study locations

1 site
  • Trygfondens Center for Aktiv Sundhed
    Copenhagen, 2100, Denmark
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 6, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07318844
Lead sponsor
Rigshospitalet, Denmark
Responsible party
Ronan Berg (Professor, MD DMSc, Rigshospitalet, Denmark) — Principal investigator
First posted
Jan 6, 2026
Start date
Sep 1, 2025
Primary completion
Dec 1, 2025
Completion
Dec 1, 2025
Last update
Jan 6, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion